Karan Bajaj, the entrepreneur behind edtech unicorn WhiteHat Jr., has raised $16 million in seed funding for his new healthtech startup, Complement1. The funding marks his entry into India’s growing digital healthcare sector after successfully building and exiting one of the country’s most recognized edtech companies.
The seed funding round was led by Owl Ventures. Existing support also came from Blume Ventures, 8VC, B Capital, and several angel investors. The fresh capital will help Complement1 develop its platform and expand its healthcare services.
Complement1 Aims to Transform Cancer Care
Initially launched in stealth mode, Complement1 is now operating publicly. The startup aims to simplify the cancer care journey by bringing diagnostics, treatment planning, ongoing care, and clinical expertise together on a single technology-driven platform.
Furthermore, the company plans to reduce the confusion and delays that many cancer patients experience while navigating different healthcare providers.
Speaking about the company’s vision, Karan Bajaj said:
“Cancer care is extremely fragmented. Patients often find themselves confused and unsupported during a very vulnerable time. We want to change that with an end-to-end platform that combines world-class clinical care, research, and technology.”
Expansion Plans
Karan Bajaj gained widespread recognition during the COVID-19 pandemic when BYJU’S acquired WhiteHat Jr. for $300 million. Now, he is focusing on healthcare with the goal of building an integrated cancer care platform.
The startup plans to launch its initial services in selected Indian cities before expanding into additional markets. Additionally, Complement1 will use the newly raised funds to strengthen its technology platform, hire medical professionals, and support product development.
The company also plans to build partnerships with healthcare providers to deliver a more connected and patient-friendly experience.
Speaking about the investment, Amit Patel, Managing Director at Owl Ventures, said:
“Owl Ventures has backed Karan before, and we’re excited to support him again in a completely new domain. The problem he’s solving is massive, and it requires the kind of structured thinking he brings to the table.”
Addressing India's Growing Healthcare Challenge
India continues to witness a steady rise in cancer cases. However, many patients still struggle to access structured, affordable, and coordinated treatment. Complement1 aims to bridge this gap by combining advanced technology with expert clinical care and a patient-first approach.
Moreover, the startup hopes to improve the overall treatment experience by making cancer care more accessible, organised, and easier to navigate.
As India’s healthtech ecosystem continues to expand, Complement1’s launch represents an important step toward modernising cancer care. Ultimately, the company aims to create a scalable healthcare model that could improve patient outcomes while driving broader healthcare innovation across the country.